Replies to post #103931 on Biotech Values

[EyeamBill]

More Potential MNTA Pipeline Candidates

I cropped this from "The Mother Of All Posts MNTA," which is my moniker only. It has Integrilin on it that has vast market potential in hospitals.

#msg-49883723 MNTA is a beneficiary of US FoB legislation
#msg-48581353 What the new healthcare law says about FoB’s
#msg-26837144 Momenta’s mantra on biogenerics
#msg-53728063 Prognostic value of FDA’s actions vis-à-vis Copaxone and FoB’s
#msg-44688351 Why M178 was dropped
#msg-52853238 Speculation re Orencia FoB
#msg-54034992 Speculation re Integrilin FoB
#msg-33839321 Procognia is not a serious competitor
#msg-33597614 Also-ran companies in the FoB arena

[DFRAI]

Dewdiligence
I dont think there is much oportunities for MNTA in any of the targets as many belong to Roche/Novartis and others are interferons (no future) etc